nach oben

Erschienen in:

09.01.2017 | Special Feature

Objection to postoperative radiation therapy in breast cancer with one to three lymph nodes involvements

verfasst von: Takashi Ishikawa, Hiroshi Kaise, Kimito Yamada, Mari Hosonaga, Takashi Chishima, Kazutaka Narui, Akimitsu Yamada, Sadatoshi Sugae, Yasushi Ichikawa, Mitsuyoshi Ota, Miyako Nozaki, Ryuji Mikami, Koichi Tokuuye

Erschienen in: Breast Cancer | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

My arguments regarding postmastectomy radiotherapy (PMRT) for this case are based on the following 4 reasons: (1) high rate of local recurrence in the no PMRT group in the Early Breast Cancer Trialists’ Collaborative Group meta-analysis on which the present guideline is based, (2) stage migration by sentinel node biopsy, (3) possible adverse events of radiotherapy, and (4) problems on extrapolation of data from western countries.

Southwest Oncology Group (SWOG). Randomized trial of postmastectomy radiotherapy in stage II breast cancer in women with one to three positive axillary nodes, phase III (SWOG 9927). http://www.swog.org/visitors/clinicaltrials.asp.

Kunkler IH, Canney P, van Tienhoven G, Russell NS. MRC/EORTC (BIG 2-04) SUPREMO Trial Management Group. Elucidating the role of chest wall irradiation in ‘intermediate-risk’ breast cancer: the MRC/EORTC SUPREMO trial. Clin Oncol (R Coll Radiol). 2008;20(1):31–4.CrossRef

McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. EBCTCG (Early Breast Cancer Trialists’ Collaborative Group). Lancet. 2014;383(9935):2127–35.CrossRefPubMed

Matsunuma R, Oguchi M, Fujikane T, Matsuura M, Sakai T, Kimura K, et al. Influence of lymphatic invasion on locoregional recurrence following mastectomy: indication for postmastectomy radiotherapy for breast cancer patients with one to three positive nodes. Int J Radiat Oncol Biol Phys. 2012;83(3):845–52. doi:10.1016/j.ijrobp.2011.08.029 (Epub 2011 Dec 3).CrossRefPubMed

Taghian A, Jeong JH, Mamounas E, Anderson S, Bryant J, Deutsch M, et al. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol. 2004;22(21):4247–54 (Epub 2004 Sep 27).CrossRefPubMed

Peto R, Davies C, Godwin J, Gray R, Pan HC, Clarke M, et al. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Lancet. 2012;379(9814):432–44. doi:10.1016/S0140-6736(11)61625-5 (Epub 2011 Dec 5).CrossRefPubMed

Maaskant AJ, van de Poll-Franse LV, Voogd AC, Coebergh JW, Tutein Nolthenius-Puylaert MC, et al. Stage migration due to introduction of the sentinel node procedure: a population-based study. Breast Cancer Res Treat. 2009;113(1):173–9. doi:10.1007/s10549-008-9913-8 (Epub 2008 Feb 8).CrossRefPubMed

McBride A, Allen P, Woodward W, Kim M, Kuerer HM, et al. Locoregional recurrence risk for patients with T1,2 breast cancer with 1–3 positive lymph nodes treated with mastectomy and systemic treatment. Int J Radiat Oncol Biol Phys. 2014;89(2):392–8. doi:10.1016/j.ijrobp.2014.02.013 (Epub 2014 Apr 7).CrossRefPubMed

Huo D, Hou N, Jaskowiak N, Winchester DJ, Winchester DP, Yao K. Use of postmastectomy radiotherapy and survival rates for breast cancer patients with T1–T2 and one to three positive lymph nodes. Ann Surg Oncol. 2015;22(13):4295–304. doi:10.1245/s10434-015-4528-x (Epub 2015 Mar 28).CrossRefPubMed

10.

Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Brønnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368(11):987–98. doi:10.1056/NEJMoa1209825.CrossRefPubMed

11.

Warren LE, Miller CL, Horick N, Skolny MN, Jammallo LS, Sadek BT, et al. The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: a prospective cohort study. Int J Radiat Oncol Biol Phys. 2014;88(3):565–71.CrossRefPubMedPubMedCentral

12.

Guidelines for diagnosis and treatment of carcinoma of the stomach. 2010 edited by the Japanese Gastric Cancer Society. Kanehara Shuppan.

13.

OECD OBESITY Update June 2014. http://www.oecd.org/health/Obesity-Update-2014.pdf.

14.

Poortmans PM, Collette S, Kirkove C, Van Limbergen E, Budach V, Struikmans H, et al. EORTC radiation oncology and breast cancer groups. Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med. 2015;373:317–27.CrossRefPubMed

15.

Whelan TJ, Olivotto IA, Parulekar WR, Ackerman I, Chua BH, Nabid A, et al. MA.20 Study Investigators. Regional Nodal Irradiation in Early-Stage Breast Cancer. N Engl J Med. 2015;373(4):307–16.CrossRefPubMedPubMedCentral

Titel: Objection to postoperative radiation therapy in breast cancer with one to three lymph nodes involvements
verfasst von: Takashi Ishikawa
Hiroshi Kaise
Kimito Yamada
Mari Hosonaga
Takashi Chishima
Kazutaka Narui
Akimitsu Yamada
Sadatoshi Sugae
Yasushi Ichikawa
Mitsuyoshi Ota
Miyako Nozaki
Ryuji Mikami
Koichi Tokuuye
Publikationsdatum: 09.01.2017
Verlag: Springer Japan
Erschienen in: Breast Cancer / Ausgabe 4/2017
Print ISSN: 1340-6868
Elektronische ISSN: 1880-4233
DOI: https://doi.org/10.1007/s12282-016-0749-5

Neu im Fachgebiet Onkologie

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Objection to postoperative radiation therapy in breast cancer with one to three lymph nodes involvements

Abstract

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2017

Atypical femoral fracture after receiving antiresorptive drugs in breast cancer patients with bone metastasis

Long non-coding RNA TUG1 promotes cell proliferation and metastasis in human breast cancer

Evaluation of the sonographic visibility and sonographic appearance of the breast biopsy marker (UltraClip®) placed in phantoms and patients

NFκBP65 transcription factor modulates resistance to doxorubicin through ABC transporters in breast cancer

Overcalling low-risk findings: grouped amorphous calcifications found at screening mammography associated with minimal cancer risk

The role of miR-130a in cancer

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie